公司資料
Invitae 股價、新聞與催化劑
- 股票代碼:
- NVTA
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for NVTA.
公司概覽
業務概覽
Invitae was a genetic-testing company focused on broad clinical genetic information and testing services before its restructuring and public-market exit. Its business was built around access to genetic data at scale.
所在地與產業分類
Headquartered in the United States and listed on NYSE before restructuring, Invitae sat in diagnostics and genomics.
商業模式特徵
The company depended on test volume, reimbursement, and the challenge of scaling consumer and clinical genetics.
生技產業定位
Invitae is now best viewed as a legacy genomics company rather than a live public-market catalyst story.
未來催化劑
- Invitae is now mostly a legacy genetics and restructuring story, so the catalysts are balance-sheet, strategic, and closeout related rather than pipeline-driven. Investors will care about whatever clarifies the company’s end state.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。